VIKING GLOBAL INVESTORS LP - Q1 2022 holdings

$24.7 Billion is the total value of VIKING GLOBAL INVESTORS LP's 91 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 51.6% .

 Value Shares↓ Weighting
TMUS BuyT-MOBILE US INC$1,722,223,000
+12.9%
13,418,175
+2.1%
6.96%
+58.5%
AMZN BuyAMAZON COM INC$1,378,480,000
+48.6%
422,853
+52.0%
5.57%
+108.6%
MSFT BuyMICROSOFT CORP$1,023,317,000
+3.7%
3,319,116
+13.2%
4.14%
+45.6%
PH BuyPARKER-HANNIFIN CORP$898,195,000
-7.6%
3,165,334
+3.5%
3.63%
+29.6%
FTV BuyFORTIVE CORP$733,180,000
+13.3%
12,033,157
+41.8%
2.96%
+58.9%
APG BuyAPI GROUP CORP$703,731,000
-18.1%
33,463,200
+0.4%
2.84%
+14.9%
MA NewMASTERCARD INCORPORATEDcl a$640,957,0001,793,488
+100.0%
2.59%
WDAY BuyWORKDAY INCcl a$539,616,000
+12.8%
2,253,470
+28.7%
2.18%
+58.3%
AON BuyAON PLC$518,755,000
+14.3%
1,593,080
+5.5%
2.10%
+60.3%
IFF BuyINTERNATIONAL FLAVORS&FRAGRA$498,690,000
+547.8%
3,797,230
+643.1%
2.02%
+808.1%
HDB BuyHDFC BANK LTDsponsored ads$433,807,000
+37.4%
7,073,317
+45.8%
1.75%
+92.7%
RPRX BuyROYALTY PHARMA PLC$419,384,000
+2.0%
10,764,472
+4.4%
1.70%
+43.2%
GH BuyGUARDANT HEALTH INC$385,002,000
-24.1%
5,812,234
+14.5%
1.56%
+6.5%
MMC BuyMARSH & MCLENNAN COS INC$383,555,000
+74.9%
2,250,643
+78.4%
1.55%
+145.4%
MTCH BuyMATCH GROUP INC NEW$298,433,000
+18.8%
2,744,468
+44.5%
1.21%
+66.7%
BMRN BuyBIOMARIN PHARMACEUTICAL INC$289,310,000
+14.1%
3,752,393
+30.7%
1.17%
+60.3%
TMO BuyTHERMO FISHER SCIENTIFIC INC$286,286,000
+103.3%
484,696
+129.7%
1.16%
+185.0%
XP NewXP INCcl a$284,244,0009,443,312
+100.0%
1.15%
OTIS NewOTIS WORLDWIDE CORP$272,262,0003,538,164
+100.0%
1.10%
NOW BuySERVICENOW INC$245,282,000
+68.5%
440,450
+96.4%
0.99%
+136.8%
CTLT BuyCATALENT INC$210,005,000
+44.0%
1,893,644
+66.2%
0.85%
+102.1%
NTLA BuyINTELLIA THERAPEUTICS INC$179,405,000
-3.9%
2,468,760
+56.3%
0.72%
+34.8%
GLBE BuyGLOBAL E ONLINE LTD$173,239,000
-45.8%
5,128,448
+1.8%
0.70%
-23.9%
BEKE BuyKE HLDGS INCsponsored ads$166,254,000
+183.0%
13,440,125
+360.2%
0.67%
+297.6%
LI BuyLI AUTO INCsponsored ads$154,872,000
+7.6%
6,000,478
+33.8%
0.63%
+50.8%
SHOP NewSHOPIFY INCcl a$151,226,000223,721
+100.0%
0.61%
CRL BuyCHARLES RIV LABS INTL INC$148,134,000
+0.8%
521,653
+33.7%
0.60%
+41.6%
ACHC BuyACADIA HEALTHCARE COMPANY IN$139,607,000
+10.0%
2,130,433
+1.9%
0.56%
+54.1%
ZLAB BuyZAI LAB LTDadr$137,802,000
-27.4%
3,133,297
+3.8%
0.56%
+1.8%
KRTX BuyKARUNA THERAPEUTICS INC$123,537,000
+9.2%
974,345
+12.8%
0.50%
+53.1%
PGR NewPROGRESSIVE CORP$118,243,0001,037,306
+100.0%
0.48%
PVH BuyPVH CORPORATION$118,161,000
+44.1%
1,542,375
+100.6%
0.48%
+102.5%
BHVN BuyBIOHAVEN PHARMACTL HLDG CO L$114,555,000
+138.3%
966,139
+177.0%
0.46%
+235.5%
PRGO NewPERRIGO CO PLC$97,046,0002,525,266
+100.0%
0.39%
MET NewMETLIFE INC$95,733,0001,362,166
+100.0%
0.39%
NewAMYLYX PHARMACEUTICALS INC$92,141,0007,170,536
+100.0%
0.37%
DG NewDOLLAR GEN CORP NEW$86,451,000388,317
+100.0%
0.35%
INSP NewINSPIRE MED SYS INC$79,800,000310,881
+100.0%
0.32%
ANTM NewANTHEM INC$69,210,000140,895
+100.0%
0.28%
BX NewBLACKSTONE INC$64,687,000509,587
+100.0%
0.26%
CLDX BuyCELLDEX THERAPEUTICS INC NEW$62,897,000
+114.8%
1,846,647
+143.7%
0.25%
+202.4%
BA NewBOEING CO$58,474,000305,347
+100.0%
0.24%
PHVS BuyPHARVARIS N V$46,382,000
+19.4%
2,480,319
+1.0%
0.19%
+67.9%
UNH NewUNITEDHEALTH GROUP INC$39,222,00076,910
+100.0%
0.16%
OHPAU BuyORION ACQUISITION CORPunit 02/19/2026$37,244,000
+3.0%
3,788,774
+3.3%
0.15%
+45.2%
UNM NewUNUM GROUP$35,847,0001,137,645
+100.0%
0.14%
JPM NewJPMORGAN CHASE & CO$16,318,000119,706
+100.0%
0.07%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-05-16
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
VISA INC36Q3 20237.0%
AMAZON COM INC34Q3 202310.6%
META PLATFORMS INC34Q3 202310.4%
MICROSOFT CORP30Q3 20239.1%
THERMO FISHER SCIENTIFIC INC29Q3 20235.4%
NETFLIX INC26Q2 20236.0%
MASTERCARD INCORPORATED25Q3 20233.9%
ELEVANCE HEALTH INC24Q2 202310.2%
ALPHABET INC22Q2 20219.3%
UNITEDHEALTH GROUP INC22Q3 20235.3%

View VIKING GLOBAL INVESTORS LP's complete holdings history.

Latest significant ownerships (13-D/G)
VIKING GLOBAL INVESTORS LP Q1 2022 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Celldex Therapeutics, Inc.Sold outFebruary 14, 202300.0%
Coupa Software IncSold outFebruary 14, 202300.0%
FIGS, Inc.Sold outFebruary 14, 202300.0%
Guardant Health, Inc.February 14, 20234,107,6444.0%
Orion Acquisition Corp.Sold outFebruary 14, 202300.0%
PROCEPT BioRobotics CorpSold outFebruary 14, 202300.0%
Frazier Lifesciences Acquisition CorpSold outNovember 25, 202200.0%
Cazoo Group LtdNovember 10, 202260,000,0007.3%
AbCellera Biologics Inc.Sold outFebruary 14, 202200.0%
Athira Pharma, Inc.Sold outFebruary 14, 202200.0%

View VIKING GLOBAL INVESTORS LP's complete significant-ownership history.

Latest filings
TypeFiled
32024-03-20
SC 13G/A2024-03-20
42024-03-07
42024-03-07
42024-03-01
42024-03-01
SC 13G/A2024-03-01
42024-02-28
42024-02-28
SC 13G/A2024-02-28

View VIKING GLOBAL INVESTORS LP's complete filings history.

Compare quarters

Export VIKING GLOBAL INVESTORS LP's holdings